-15 -14 -13 -12 -11 -10 -09 -08 -07 -06 -05 -04 -03 -02 -01 | page 01 of 06 |
+01 +02 +03 +04 +05 +06 +07 +08 +09 +10 +11 +12 +13 +14 +15 | <- Back | Next page -> |
16-0017 CEP ECCMID16_A5_Flier R3 (002).pdf | ||
2011-05-1 VT MycoLine | ||
2011-05-2 DiaSorin MMRV | ||
2011-10-13 Cepheid | ||
2012-01 MG HCV,HIV,Trepo | ||
2012-03-1 MG Yersinia | ||
2012-04-1 MG HEV | ||
2012-07 MG recomBead | ||
2012-07-2 MG ampliCube HEV | ||
2012-08 QI Complement | ||
2012-12 suPARnostic | ||
2013-02 EC Peptest | ||
2013-02 FO Dengue | ||
2013-02 Invit MG HEV Berlin | ||
2013-05 Check-Direct | ||
2013-05 IMMY CrAg | ||
2013-07 Vircell | ||
2013-10 VT Liquor Nьrnberg | ||
2014-02 Biohit Announcement | ||
2014-02_MG-Mailing | ||
2014-03 BioHit Announcement | ||
2014-03 VC-PneumoIFA | ||
2014-04 VC-Brucellacapt | ||
2014-04a VC-ACRESI | ||
2014-05 AmpliRun | ||
2014-05 HAI Cepheid | ||
2014-05 IFCPC | ||
2014-05-CE Integrated Symposium IFCPC | ||
2014-06 VirClia Monotest | ||
2014-07 - Celiac |
-15 -14 -13 -12 -11 -10 -09 -08 -07 -06 -05 -04 -03 -02 -01 | page 01 of 06 |
+01 +02 +03 +04 +05 +06 +07 +08 +09 +10 +11 +12 +13 +14 +15 | <- Back | Next page -> |